Pfizer prices Covid-19 treatment Paxlovid at $1,390 - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- Kroger cuts same-store sales outlook, keeps earnings guidance
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Pfizer (PFE) PT Lowered to $39 at Morgan Stanley
October 17, 2023 8:50 AM EDTMorgan Stanley analyst Terence Flynn lowered the price target on Pfizer (NYSE: PFE) to $39.00 (from $40.00) while maintaining a Equalweight rating.... More
Pfizer (PFE) PT Lowered to $42 at Truist Securities
October 17, 2023 7:19 AM EDTTruist Securities analyst Robyn Karnauskas lowered the price target on Pfizer (NYSE: PFE) to $42.00 (from $62.00) while maintaining a Buy rating.... More
